Samah Nassereddine MD

Blood 🩸 Doctor and a strong patient advocate

@Gwcancer @GW_MFA
Hematology/Oncology

[Samah Nassereddine MD @SamahNd]

After an amazing night with @washingtonian, now heading to @ASH_hematology #ASH2023
So Thankful for all my colleagues and my patients.
Thank you @GWCancer and @GWHospital

[Samah Nassereddine MD @SamahNd]

And it is a wrap #ASH2024

[Samah Nassereddine MD @SamahNd]

Strong work as usual Dr Issa..more hope for our AML patients

[Ghayas Issa @GhayasIssa]

Menin inhibition is a standard of care! FDA approval of revumenib!! So happy to see that the benefit witnessed in patients on study is leading to a medicine to all who need it. Ready to forj ahead with more to come! ;)

[Ghayas Issa @GhayasIssa]

The first BTC trial to target AML MRD with combination of menin and BCL2 inhibition is now open! Huge team effort and more exciting trials for MRD to come. Goal is to better measure, understand and treat MRD

[Samah Nassereddine MD @SamahNd]

@malaksalharbi1 Wishing you great success with your boards and next steps in your career.

[Samah Nassereddine MD @SamahNd]

@Charbel_matar1 shout out to this super star 🌟 fellow for presenting rare cases of HL arising in patients with CLL at @SocietyofHemOnc @GWCancer

[Samah Nassereddine MD @SamahNd]

Hematology rounds
Very demure, very mindful
@GWCancer

[Samah Nassereddine MD @SamahNd]

It was an incredible night launching our first MidAntlantic Fellow Blood 🩸 Club bringing institutions and fellows together.
Thank you for everyone for making this a reality and our moderators and speakers.
@DunleavyKieron, Dr Aarti shenoy and Dr J. Kanakri

[Samah Nassereddine MD @SamahNd]

Proud that at @GWCancer and @GWSMHS our Dean, our cancer center director and our chief of division are all woman.
@AAMCtoday

[Samah Nassereddine MD @SamahNd]

So proud of Dr @Charbel_matar1
What a great representation to our cancer center @GWCancer

[Charbel Matar @Charbel_matar1]

Thrilled to be part of this amazing talented group of featured voices #ASCO2024 for the third year 🎉 Follow the team for more insight on the most updated conference in Oncology 2024.

@HamidMD10 @jacobadashek @TwoOncDocs @DarcyBurbage @fumikochino @DevikaDasMD @ADesaiMD

[Firas El Chaer, MD, MSHCM @FirasElChaer]

I am excited to present this oral presentation at @EHA_Hematology on the value of MRD in AML **as it is currently performed** from the @CIBMTR database @page_md @DrChrisHourigan
https://t.co/noSD15XLuy

[Javier Bolaños Meade, MD @GvHD_Meade]

Another disease where BMT is starting to look irrelevant (too early to tell for sure) TRIANGLE: a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network - The Lancet https://t.co/swViRIdmqS

[Samah Nassereddine MD @SamahNd]

@lab_rezvani @kchenken @mdaher @MDAndersonNews Bravo 🎉 @may_daher

[Dr. Catherine Lai @KatieLaiMD_MPH]

Thank you Dr. Gustavo Rivera and @OncLive for hosting a wonderful discussion on AML! And even better to see colleagues @CarrawayHetty @LaceyWilliamsMD @SamahNd Aarthi Shenoy at my old stomping ground @MedStarGUH

[Dalia M. @DCCancerDoc]

@SamahNd @Cancer_talks @GWCancer
Excellent talk on AML at 2024 Hematology Update Symposium by
Dr. Nassereddine

[Samah Nassereddine MD @SamahNd]

What an amazing way to end the #ASH23 celebrating Dr Rezvani Donnall award & so proud of my friends @may_daher @HindRafei for following the leads of an impressive leader in cellular therapy.

[Dr. Catherine Lai @KatieLaiMD_MPH]

Hanging out with my DC contingent! @FirasElChaer @SamahNd #ASH2023

[Katy Rezvani, M.D., Ph.D @lab_rezvani]

Outstanding presentations by ⁦@may_daher⁩ & ⁦@Byersdoc_BMT⁩ at the Immunometabolism as a tool to advance cell therapy session #ASH23 describing novel strategies to modulate and enhance the potency of immune effector cells for adoptive therapy ⁦@MDAndersonNews⁩

[Samah Nassereddine MD @SamahNd]

The best of #ash23 @KatieLaiMD_MPH @FirasElChaer

[Samah Nassereddine MD @SamahNd]

@KatieLaiMD_MPH @CART4AML Well done 🙏

[Raul Cordoba, MD, PhD @DrRaulCordoba]

N-AVD vs BV-AVD in older patients with #Hodgkin #lymphoma. No words needed. To me, the new SoC #lymsm #ASH23